Maxwell Biosciences Alternatives & Competitors
12 companies similar to Maxwell Biosciences — Next Generation Anti-Infectives: A drug platform confirmed by independent labs t...
Companies similar to Maxwell Biosciences
Adaptive Phage Therapeutics
To save lives or restore health as a leader in safe, rapidly deployable, cost-effective cu...
Gaithersburg, United Stat...
Alpha Genesis Inc.
Full-Service Nonhuman Primate Research Solutions
United States
Rival Readout
Competing with Maxwell Biosciences? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
BioVersys AG
Leadership in overcoming the antibiotic resistance crisis.
Basel, Switzerland
MerLion Pharmaceuticals GmbH
Researches and develops drugs based on natural products
Germany
Clarametyx Biosciences
Targeting biofilms to treat chronic respiratory disease
Columbus, United States
DEM Biopharma, Inc.
Novel Target for Solid Tumors
Cambridge, United States
Intract Pharma
Transforming Patient Care by Replacing Injections with Safer, More Effective Therapeutics...
London, United Kingdom
Endevica Bio
Reversing cachexia and improving quality of life in cancer patients. Phase 1 trial underwa...
Columbia, United States
FogPharma
Until everything is druggable.
Cambridge, United States
Generate:Biomedicines
Pioneering generative biology to create breakthrough therapeutics.
Somerville, United States
About Maxwell Biosciences
Maxwell Biosciences, founded in 2016 and headquartered in the United States, is making significant strides in the biopharmaceutical industry with its innovative 'Next Generation Anti-Infectives' platform. The company aims to revolutionize antiviral and antimicrobial treatments by developing low molecular weight drug ca...
Drug development for infectious diseases, Peptoid-based therapeutic solutions, Research in proteomics and immunology, Biodefense and anti-infective research
Healthcare providers, Biotechnology research organizations, Government and biodefense agencies, Pharmaceutical companies
Drug Development, Antimicrobial Peptides, Antiviral Drugs, Preclinical Stage, Patented Technology, Viral Pandemics, Infectious Pathogens, Clinical Trials, Fungal Infections, Antiviral Research, Grants And Awards, Virus Destruction, Drug Platform, Investor Opportunity
Platform, B2B, B2G
Licensing, Performance Based, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Maxwell Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Maxwell Biosciences on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 21 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
